Reuters - Video

Edition: US | UK | IN | CN | JP

Finance Videos

Valeant needs to find stability, more transparency-Jeff Loo

Wednesday, March 09, 2016 - 04:18

S&P Investment Advisory Services Jeffrey Loo talks about why he has a ''buy'' rating on controversial drug company Valeant, which just added three new members to its board. Bobbi Rebell reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Valeant needs to find stability, more transparency-Jeff Loo

Wednesday, March 09, 2016 - 04:18